#,ama,title,journal,year,volume,issue,pages,doi,pmid,authors
1,"Sung H, Ferlay J, Siegel RL. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71.",Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries,CA Cancer J Clin,2021,71,,,,,Sung H; Ferlay J; Siegel RL
2,"Islami F, Ward EM, Sung H. Annual report to the nation on the status of cancer, Part 1: National cancer statistics. J Natl Cancer Inst. 2021;113.","Annual report to the nation on the status of cancer, Part 1: National cancer statistics",J Natl Cancer Inst,2021,113,,,,,Islami F; Ward EM; Sung H
3,"Henley SJ, Thomas CC, Lewis DR. Annual report to the nation on the status of cancer, part II: Progress toward Healthy People 2020 objectives for 4 common cancers. Annual report to the nation on the status of cancer, part II: Progress toward Healthy People 2020 objectives for 4 common cancers. 2020;126.","Annual report to the nation on the status of cancer, part II: Progress toward Healthy People 2020 objectives for 4 common cancers","Annual report to the nation on the status of cancer, part II: Progress toward Healthy People 2020 objectives for 4 common cancers",2020,126,,,,,Henley SJ; Thomas CC; Lewis DR
4,"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73.","Cancer statistics, 2023",CA Cancer J Clin,2023,73,,,,,Siegel RL; Miller KD; Wagle NS; Jemal A
5,"Fedewa SA, Bandi P, Smith RA. Lung cancer screening rates during the COVID-19 pandemic. Chest. 2022;161.",Lung cancer screening rates during the COVID-19 pandemic,Chest,2022,161,,,,,Fedewa SA; Bandi P; Smith RA
6, SEER*Explorer: An interactive website for SEER cancer statistics. SEER*Explorer: An interactive website for SEER cancer statistics. None;None.,SEER*Explorer: An interactive website for SEER cancer statistics,SEER*Explorer: An interactive website for SEER cancer statistics,,,,,,,
7,"Jemal A, Ward EM, Johnson CJ. Annual report to the nation on the status of cancer, 1975-2014, featuring survival. J Natl Cancer Inst. 2017;109.","Annual report to the nation on the status of cancer, 1975-2014, featuring survival",J Natl Cancer Inst,2017,109,,,,,Jemal A; Ward EM; Johnson CJ
8,"Jemal A, Thun MJ, Ries LA. Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst. 2008;100.","Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control",J Natl Cancer Inst,2008,100,,,,,Jemal A; Thun MJ; Ries LA
9,"Lung N, Trial Research S, Aberle T, Berg DR, CD. The National Lung Screening Trial: overview and study design. Radiology. 2011;258.",The National Lung Screening Trial: overview and study design,Radiology,2011,258,,,,,Lung N; Trial Research S; Aberle T; Berg DR; CD
10,"De Koning HJ, Van Der Aalst CM, Jong PA. Reduced lungcancer mortality with volume CT screening in a randomized trial. N Engl J Med. 2020;382.",Reduced lungcancer mortality with volume CT screening in a randomized trial,N Engl J Med,2020,382,,,,,De Koning HJ; Van Der Aalst CM; Jong PA
11,"Lung N, Trial Research S, Aberle T, Adams DR, AM. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365.",Reduced lung-cancer mortality with low-dose computed tomographic screening,N Engl J Med,2011,365,,,,,Lung N; Trial Research S; Aberle T; Adams DR; AM
12,"Sands J, Tammemagi MC, Couraud S. Lung screening benefits and challenges: A review of the data and outline for implementation. J Thorac Oncol. 2021;16.",Lung screening benefits and challenges: A review of the data and outline for implementation,J Thorac Oncol,2021,16,,,,,Sands J; Tammemagi MC; Couraud S
13,"Lung N, Research ST, T. Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial. J Thorac Oncol. 2019;14.",Lung Cancer Incidence and Mortality with Extended Follow-up in the National Lung Screening Trial,J Thorac Oncol,2019,14,,,,,Lung N; Research ST; T
14,"Walter FM, Rubin G, Bankhead C. Symptoms and other factors associated with time to diagnosis and stage of lung cancer: a prospective cohort study. Br J Cancer. 2015;112(Suppl 1).",Symptoms and other factors associated with time to diagnosis and stage of lung cancer: a prospective cohort study,Br J Cancer,2015,112,Suppl 1,,,,Walter FM; Rubin G; Bankhead C
15,"Okoli GN, Kostopoulou O, Delaney BC. Is symptom-based diagnosis of lung cancer possible? A systematic review and meta-analysis of symptomatic lung cancer prior to diagnosis for comparison with real-time data from routine general practice. PLoS One. 2018;13:207686.",Is symptom-based diagnosis of lung cancer possible? A systematic review and meta-analysis of symptomatic lung cancer prior to diagnosis for comparison with real-time data from routine general practice,PLoS One,2018,13,,207686,,,Okoli GN; Kostopoulou O; Delaney BC
16,"Aberle DR, Demello S, Berg CD. Results of the two incidence screenings in the National Lung Screening Trial. N Engl J Med. 2013;369.",Results of the two incidence screenings in the National Lung Screening Trial,N Engl J Med,2013,369,,,,,Aberle DR; Demello S; Berg CD
17,"Kramer BS, Berg CD, Aberle DR, Prorok PC. Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST). J Med Screen. 2011;18.",Lung cancer screening with low-dose helical CT: results from the National Lung Screening Trial (NLST),J Med Screen,2011,18,,,,,Kramer BS; Berg CD; Aberle DR; Prorok PC
18,Midthun DE. Screening for lung cancer. Clin Chest Med. 2011;32.,Screening for lung cancer,Clin Chest Med,2011,32,,,,,Midthun DE
19,"Liu Y, Pan IE, Tak HJ. Assessment of uptake appropriateness of computed tomography for lung cancer screening according to patients meeting eligibility criteria of the US Preventive Services Task Force. JAMA Netw Open. 2022;5:2243163.",Assessment of uptake appropriateness of computed tomography for lung cancer screening according to patients meeting eligibility criteria of the US Preventive Services Task Force,JAMA Netw Open,2022,5,,2243163,,,Liu Y; Pan IE; Tak HJ
20,"Richards TB, Soman A, Thomas CC. Screening for lung cancer -10 states, 2017. MMWR Morb Mortal Wkly Rep. 2020;69.","Screening for lung cancer -10 states, 2017",MMWR Morb Mortal Wkly Rep,2020,69,,,,,Richards TB; Soman A; Thomas CC
21,"Oken MM, Hocking WG, Kvale PA. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial. JAMA. 2011;306.","Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial",JAMA,2011,306,,,,,Oken MM; Hocking WG; Kvale PA
22,"Moyer VA, Force U. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014;160.",Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement,Ann Intern Med,2014,160,,,,,Moyer VA; Force U
23,"Detterbeck FC, Mazzone PJ, Naidich DP, Bach PB. Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013;143.","Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines",Chest,2013,143,,,,,Detterbeck FC; Mazzone PJ; Naidich DP; Bach PB
24,"Vachani A, Carroll NM, Simoff MJ. Stage migration and lung cancer incidence after initiation of low-dose computed tomography screening. J Thorac Oncol. 2022;17.",Stage migration and lung cancer incidence after initiation of low-dose computed tomography screening,J Thorac Oncol,2022,17,,,,,Vachani A; Carroll NM; Simoff MJ
25,"Flores R, Patel P, Alpert N. Association of stage shift and population mortality among patients with non-small cell lung cancer. JAMA Netw Open. 2021;4:2137508.",Association of stage shift and population mortality among patients with non-small cell lung cancer,JAMA Netw Open,2021,4,,2137508,,,Flores R; Patel P; Alpert N
26,"Potter AL, Rosenstein AL, Kiang MV. Association of computed tomography screening with lung cancer stage shift and survival in the United States: quasi-experimental study. BMJ. 2022;376:69008.",Association of computed tomography screening with lung cancer stage shift and survival in the United States: quasi-experimental study,BMJ,2022,376,,69008,,,Potter AL; Rosenstein AL; Kiang MV
27,"Yang CY, Lin YT, Lin LJ. Stage shift improves lung cancer survival: Real-world evidence. J Thorac Oncol. 2023;18.",Stage shift improves lung cancer survival: Real-world evidence,J Thorac Oncol,2023,18,,,,,Yang CY; Lin YT; Lin LJ
28,"Silvestri GA, Goldman L, Tanner NT. Outcomes from more than 1 million people screened for lung cancer with low-dose CT imaging. Chest. 2023;164.",Outcomes from more than 1 million people screened for lung cancer with low-dose CT imaging,Chest,2023,164,,,,,Silvestri GA; Goldman L; Tanner NT
29,"Wood DE, Eapen GA, Ettinger DS. Lung cancer screening. J Natl Compr Canc Netw. 2012;10.",Lung cancer screening,J Natl Compr Canc Netw,2012,10,,,,,Wood DE; Eapen GA; Ettinger DS
30,Wood DE. Lung cancer screening: the last 10 years. J Natl Compr Canc Netw. 2012;10.,Lung cancer screening: the last 10 years,J Natl Compr Canc Netw,2012,10,,,,,Wood DE
31,"Milligan MG, Lennes IT, Hawari S. Incidence of radiation therapy among patients enrolled in a multidisciplinary pulmonary nodule and lung cancer screening clinic. JAMA Netw Open. 2022;5:224840.",Incidence of radiation therapy among patients enrolled in a multidisciplinary pulmonary nodule and lung cancer screening clinic,JAMA Netw Open,2022,5,,224840,,,Milligan MG; Lennes IT; Hawari S
32,"Timmerman R, Paulus R, Galvin J. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303.",Stereotactic body radiation therapy for inoperable early stage lung cancer,JAMA,2010,303,,,,,Timmerman R; Paulus R; Galvin J
33,"Ma Ij, Shoni M, Siegert C. Survival after stereotactic body radiation therapy for clinically diagnosed or biopsy-proven early-stage NSCLC: A systematic review and meta-analysis. J Thorac Oncol. 2019;14.",Survival after stereotactic body radiation therapy for clinically diagnosed or biopsy-proven early-stage NSCLC: A systematic review and meta-analysis,J Thorac Oncol,2019,14,,,,,Ma Ij; Shoni M; Siegert C
34,"Travis WD, Brambilla E, Noguchi M. International association the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6.",International association the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma,J Thorac Oncol,2011,6,,,,,Travis WD; Brambilla E; Noguchi M
35, Thoracic Tumours: WHO Classification of Tumours. Thoracic Tumours: WHO Classification of Tumours. 2021;5.,Thoracic Tumours: WHO Classification of Tumours,Thoracic Tumours: WHO Classification of Tumours,2021,5,,,,,
36,"Neacsu F, Varban AS, Simion G. Lung cancer mimickers -a case series of seven patients and review of the literature. Rom J Morphol Embryol. 2021;62.",Lung cancer mimickers -a case series of seven patients and review of the literature,Rom J Morphol Embryol,2021,62,,,,,Neacsu F; Varban AS; Simion G
37,"Grunewald J, Grutters JC, Arkema EV. Nat Rev Dis Primers. Nat Rev Dis Primers. 2019;5:45.",Nat Rev Dis Primers,Nat Rev Dis Primers,2019,5,,45,,,Grunewald J; Grutters JC; Arkema EV
38,"Pinsky PF, Dunn B, Gierada D. Incidental renal tumours on lowdose CT lung cancer screening exams. J Med Screen. 2017;24.",Incidental renal tumours on lowdose CT lung cancer screening exams,J Med Screen,2017,24,,,,,Pinsky PF; Dunn B; Gierada D
39,"Gould MK, Donington J, Lynch WR. Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidencebased clinical practice guidelines. Chest. 2013;143.","Evaluation of individuals with pulmonary nodules: when is it lung cancer? Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidencebased clinical practice guidelines",Chest,2013,143,,,,,Gould MK; Donington J; Lynch WR
40,"Murrmann GB, Van Vollenhoven FH, Moodley L. Approach to a solid solitary pulmonary nodule in two different settings-""Common is common, rare is rare. J Thorac Dis. 2014;6.","Approach to a solid solitary pulmonary nodule in two different settings-""Common is common, rare is rare",J Thorac Dis,2014,6,,,,,Murrmann GB; Van Vollenhoven FH; Moodley L
41,"Dyer DS, White C, Thomson C, C. A quick reference guide for incidental findings on lung cancer screening CT examinations. J Am Coll Radiol. 2023;20.",A quick reference guide for incidental findings on lung cancer screening CT examinations,J Am Coll Radiol,2023,20,,,,,Dyer DS; White C; Thomson C; C
42,"Munden RF, Black WC, Hartman TE. Managing incidental findings on thoracic CT: Lung findings. A white paper of the ACR Incidental Findings Committee. J Am Coll Radiol. 2021;18.",Managing incidental findings on thoracic CT: Lung findings. A white paper of the ACR Incidental Findings Committee,J Am Coll Radiol,2021,18,,,,,Munden RF; Black WC; Hartman TE
43,"Munden RF, Carter BW, Chiles C. Managing incidental findings on thoracic CT: Mediastinal and cardiovascular findings. A white paper of the ACR Incidental Findings Committee. J Am Coll Radiol. 2018;15.",Managing incidental findings on thoracic CT: Mediastinal and cardiovascular findings. A white paper of the ACR Incidental Findings Committee,J Am Coll Radiol,2018,15,,,,,Munden RF; Carter BW; Chiles C
44,"Lee CI, Forman HP. CT screening for lung cancer: implications on social responsibility. AJR Am J Roentgenol. 2007;188.",CT screening for lung cancer: implications on social responsibility,AJR Am J Roentgenol,2007,188,,,,,Lee CI; Forman HP
45,"Slatore CG, Sullivan DR, Pappas M, Humphrey LL. Patient-centered outcomes among lung cancer screening recipients with computed tomography: a systematic review. J Thorac Oncol. 2014;9.",Patient-centered outcomes among lung cancer screening recipients with computed tomography: a systematic review,J Thorac Oncol,2014,9,,,,,Slatore CG; Sullivan DR; Pappas M; Humphrey LL
46,"Aberle DR, Abtin F, Brown K. Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial. J Clin Oncol. 2013;31.",Computed tomography screening for lung cancer: has it finally arrived? Implications of the national lung screening trial,J Clin Oncol,2013,31,,,,,Aberle DR; Abtin F; Brown K
47,"De Koning HJ, Meza R, Plevritis SK. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med. 2014;160.",Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force,Ann Intern Med,2014,160,,,,,De Koning HJ; Meza R; Plevritis SK
48,"Patz EF, Pinsky P, Gatsonis C. Overdiagnosis in low-dose computed tomography screening for lung cancer. JAMA Intern Med. 2014;174.",Overdiagnosis in low-dose computed tomography screening for lung cancer,JAMA Intern Med,2014,174,,,,,Patz EF; Pinsky P; Gatsonis C
49,"Mazzone PJ, Silvestri GA, Souter LH. Screening for lung cancer: CHEST guideline and expert panel report. Chest. 2021;160.",Screening for lung cancer: CHEST guideline and expert panel report,Chest,2021,160,,,,,Mazzone PJ; Silvestri GA; Souter LH
50,"Wiener RS, Gould MK, Arenberg DA. An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice. Am J Respir Crit Care Med. 2015;192.",An official American Thoracic Society/American College of Chest Physicians policy statement: implementation of low-dose computed tomography lung cancer screening programs in clinical practice,Am J Respir Crit Care Med,2015,192,,,,,Wiener RS; Gould MK; Arenberg DA
51,"Fintelmann FJ, Bernheim A, Digumarthy SR. The 10 pillars of lung cancer screening: Rationale and logistics of a lung cancer screening program. Radiographics. 2015;35.",The 10 pillars of lung cancer screening: Rationale and logistics of a lung cancer screening program,Radiographics,2015,35,,,,,Fintelmann FJ; Bernheim A; Digumarthy SR
52,"Dusendang JR, Sakoda LC, Urbania TH. An intervention to tag findings suspicious for lung cancer on chest computed tomography has good sensitivity and number needed to diagnose. Perm J. 2021;25.",An intervention to tag findings suspicious for lung cancer on chest computed tomography has good sensitivity and number needed to diagnose,Perm J,2021,25,,,,,Dusendang JR; Sakoda LC; Urbania TH
53,"Kazerooni EA, Armstrong MR, Amorosa JK. ACR CT accreditation program and the lung cancer screening program designation. J Am Coll Radiol. 2016;13.",ACR CT accreditation program and the lung cancer screening program designation,J Am Coll Radiol,2016,13,,,,,Kazerooni EA; Armstrong MR; Amorosa JK
54,"Mazzone P, Powell CA, Arenberg D. Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement. Chest. 2015;147.",Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement,Chest,2015,147,,,,,Mazzone P; Powell CA; Arenberg D
55,"Davis AM, Cifu AS. Lung cancer screening. JAMA. 2014;312.",Lung cancer screening,JAMA,2014,312,,,,,Davis AM; Cifu AS
56,"Armstrong K, Kim JJ, Halm EA. Using lessons from breast, cervical, and colorectal cancer screening to inform the development of lung cancer screening programs. Cancer. 2016;122.","Using lessons from breast, cervical, and colorectal cancer screening to inform the development of lung cancer screening programs",Cancer,2016,122,,,,,Armstrong K; Kim JJ; Halm EA
57,"Lam A, Aggarwal R, Cheung S. Predictors of participant nonadherence in lung cancer screening programs: a systematic review and meta-analysis. Lung Cancer. 2020;146.",Predictors of participant nonadherence in lung cancer screening programs: a systematic review and meta-analysis,Lung Cancer,2020,146,,,,,Lam A; Aggarwal R; Cheung S
58,"Lopez-Olivo MA, Maki KG, Choi NJ. Patient adherence to screening for lung cancer in the US: A systematic review and metaanalysis. JAMA Netw Open. 2020;3:e2025102.",Patient adherence to screening for lung cancer in the US: A systematic review and metaanalysis,JAMA Netw Open,2020,3,,e2025102,,,Lopez-Olivo MA; Maki KG; Choi NJ
59,"Tanner NT, Brasher PB, Wojciechowski B. Screening adherence in the Veterans Administration Lung Cancer Screening Demonstration Project. Chest. 2020;158.",Screening adherence in the Veterans Administration Lung Cancer Screening Demonstration Project,Chest,2020,158,,,,,Tanner NT; Brasher PB; Wojciechowski B
60,"Rivera MP, Durham DD, Long JM. Receipt of recommended follow-up care after a positive lung cancer screening examination. JAMA Netw Open. 2022;5:2240403.",Receipt of recommended follow-up care after a positive lung cancer screening examination,JAMA Netw Open,2022,5,,2240403,,,Rivera MP; Durham DD; Long JM
61,"Barbosa E, Yang R, Hershman M. Real-world lung cancer CT screening performance, smoking behavior, and adherence to recommendations: Lung-RADS category and smoking status predict adherence. AJR Am J Roentgenol. 2021;216.","Real-world lung cancer CT screening performance, smoking behavior, and adherence to recommendations: Lung-RADS category and smoking status predict adherence",AJR Am J Roentgenol,2021,216,,,,,Barbosa E; Yang R; Hershman M
62,"Erkmen CP, Dako F, Moore R. Adherence to annual lung cancer screening with low-dose CT scan in a diverse population. Cancer Causes Control. 2021;32.",Adherence to annual lung cancer screening with low-dose CT scan in a diverse population,Cancer Causes Control,2021,32,,,,,Erkmen CP; Dako F; Moore R
63,"Nunez ER, Caverly TJ, Zhang S. Adherence to follow-up testing recommendations in US veterans screened for lung cancer, 2015-2019. Lung Cancer Screening MS-34 JAMA Netw Open. 2021;2:2116233.","Adherence to follow-up testing recommendations in US veterans screened for lung cancer, 2015-2019",Lung Cancer Screening MS-34 JAMA Netw Open,2021,2,,2116233,,,Nunez ER; Caverly TJ; Zhang S
64,"Panel On Thoracic E, Donnelly I, Kazerooni EF, EA. ACR Appropriateness Criteria((R)) Lung Cancer Screening. J Am Coll Radiol. 2018;15.",ACR Appropriateness Criteria((R)) Lung Cancer Screening,J Am Coll Radiol,2018,15,,,,,Panel On Thoracic E; Donnelly I; Kazerooni EF; EA
65,"Hammer MM, Hunsaker AR. Strategies for reducing false-positive screening results for intermediate-size nodules evaluated using Lung-RADS: A secondary analysis of National Lung Screening Trial data. AJR Am J Roentgenol. 2022;219.",Strategies for reducing false-positive screening results for intermediate-size nodules evaluated using Lung-RADS: A secondary analysis of National Lung Screening Trial data,AJR Am J Roentgenol,2022,219,,,,,Hammer MM; Hunsaker AR
66,"Chelala L, Hossain R, Kazerooni EA. Lung-RADS Version 1.1: Challenges and a look ahead, from the AJR Special Series on Radiology Reporting and Data Systems. AJR Am J Roentgenol. 2021;216.","Lung-RADS Version 1.1: Challenges and a look ahead, from the AJR Special Series on Radiology Reporting and Data Systems",AJR Am J Roentgenol,2021,216,,,,,Chelala L; Hossain R; Kazerooni EA
67, Lung-RADS Assessment Categories version1.1. Lung-RADS Assessment Categories version1.1. None;None.,Lung-RADS Assessment Categories version1.1,Lung-RADS Assessment Categories version1.1,,,,,,,
68,"Mckee BJ, Regis SM, Mckee AB. Performance of ACR Lung-RADS in a clinical CT lung screening program. J Am Coll Radiol. 2016;13.",Performance of ACR Lung-RADS in a clinical CT lung screening program,J Am Coll Radiol,2016,13,,,,,Mckee BJ; Regis SM; Mckee AB
69,"Pinsky PF, Gierada DS, Black W. Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment. Ann Intern Med. 2015;162.",Performance of Lung-RADS in the National Lung Screening Trial: a retrospective assessment,Ann Intern Med,2015,162,,,,,Pinsky PF; Gierada DS; Black W
70,"Kazerooni EA, Austin JH, Black WC. ACR-STR practice parameter for the performance and reporting of lung cancer screening thoracic computed tomography (CT): 2014 (Resolution 4). J Thorac Imaging. 2014;29.",ACR-STR practice parameter for the performance and reporting of lung cancer screening thoracic computed tomography (CT): 2014 (Resolution 4),J Thorac Imaging,2014,29,,,,,Kazerooni EA; Austin JH; Black WC
71,"Karush J, Arndt A, Shah P. Improved false-positive rates and the overestimation of unintended harm from lung cancer screening. Lung. 2019;197.",Improved false-positive rates and the overestimation of unintended harm from lung cancer screening,Lung,2019,197,,,,,Karush J; Arndt A; Shah P
72,"Kaminetzky M, Milch HS, Shmukler A. Effectiveness of Lung-RADS in reducing false-positive results in a diverse, underserved, urban lung cancer screening cohort. J Am Coll Radiol. 2019;16.","Effectiveness of Lung-RADS in reducing false-positive results in a diverse, underserved, urban lung cancer screening cohort",J Am Coll Radiol,2019,16,,,,,Kaminetzky M; Milch HS; Shmukler A
73,"Munoz-Largacha JA, Steiling KA, Kathuria H. Initial surgical experience following implementation of lung cancer screening at an urban safety net hospital. J Thorac Cardiovasc Surg. 2018;155.",Initial surgical experience following implementation of lung cancer screening at an urban safety net hospital,J Thorac Cardiovasc Surg,2018,155,,,,,Munoz-Largacha JA; Steiling KA; Kathuria H
74,"Mckee BJ, Regis SM, Mckee AB. Performance of ACR Lung-RADS in a clinical CT lung screening program. J Am Coll Radiol. 2015;12.",Performance of ACR Lung-RADS in a clinical CT lung screening program,J Am Coll Radiol,2015,12,,,,,Mckee BJ; Regis SM; Mckee AB
75,"Mendoza DP, Petranovic M, Som A. Lung-RADS category 3 and 4 nodules on lung cancer screening in clinical practice. AJR Am J Roentgenol. 2022;219.",Lung-RADS category 3 and 4 nodules on lung cancer screening in clinical practice,AJR Am J Roentgenol,2022,219,,,,,Mendoza DP; Petranovic M; Som A
76,"Wiener RS, Gould MK, Woloshin S. What do you mean, a spot?: A qualitative analysis of patients' reactions to discussions with their physicians about pulmonary nodules. Chest. 2013;143.","What do you mean, a spot?: A qualitative analysis of patients' reactions to discussions with their physicians about pulmonary nodules",Chest,2013,143,,,,,Wiener RS; Gould MK; Woloshin S
77,"Goulart BH, Ramsey SD. Moving beyond the national lung screening trial: discussing strategies for implementation of lung cancer screening programs. Oncologist. 2013;18.",Moving beyond the national lung screening trial: discussing strategies for implementation of lung cancer screening programs,Oncologist,2013,18,,,,,Goulart BH; Ramsey SD
78,Sox HC. Implementing lung cancer screening under Medicare: the last chance to get it right?. JAMA. 2014;312.,Implementing lung cancer screening under Medicare: the last chance to get it right?,JAMA,2014,312,,,,,Sox HC
79,"Volk RJ, Hawk E, Bevers TB. Should CMS cover lung cancer screening for the fully informed patient?. JAMA. 2014;312.",Should CMS cover lung cancer screening for the fully informed patient?,JAMA,2014,312,,,,,Volk RJ; Hawk E; Bevers TB
80,"Dicarlo M, Myers P, Daskalakis C. Outreach to primary care patients in lung cancer screening: A randomized controlled trial. Prev Med. 2022;159:107069.",Outreach to primary care patients in lung cancer screening: A randomized controlled trial,Prev Med,2022,159,,107069,,,Dicarlo M; Myers P; Daskalakis C
81,"Doroudi M, Pinsky PF, Marcus PM. Lung cancer mortality in the Lung Screening Study Feasibility Trial. JNCI Cancer Spectr. 2018;2:42.",Lung cancer mortality in the Lung Screening Study Feasibility Trial,JNCI Cancer Spectr,2018,2,,42,,,Doroudi M; Pinsky PF; Marcus PM
82,"Humphrey LL, Deffebach M, Pappas M. Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation. Ann Intern Med. 2013;159.",Screening for lung cancer with low-dose computed tomography: a systematic review to update the US Preventive services task force recommendation,Ann Intern Med,2013,159,,,,,Humphrey LL; Deffebach M; Pappas M
83,"Midthun DE, Jett JR. Screening for lung cancer: the US studies. J Surg Oncol. 2013;108.",Screening for lung cancer: the US studies,J Surg Oncol,2013,108,,,,,Midthun DE; Jett JR
84,"Humphrey LL, Johnson M, Teutsch S. Lung cancer screening: An update for the U.S. Preventive Services Task Force. Lung cancer screening: An update for the U.S. Preventive Services Task Force. 2004;None.",Lung cancer screening: An update for the U.S. Preventive Services Task Force,Lung cancer screening: An update for the U.S. Preventive Services Task Force,2004,,,,,,Humphrey LL; Johnson M; Teutsch S
85,"Humphrey LL, Teutsch S, Johnson M, Force U. Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2004;140.","Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force",Ann Intern Med,2004,140,,,,,Humphrey LL; Teutsch S; Johnson M; Force U
86,"Callister M, Sasieni P, Robbins HA. Overdiagnosis in lung cancer screening. Lancet Respir Med. 2021;9.",Overdiagnosis in lung cancer screening,Lancet Respir Med,2021,9,,,,,Callister M; Sasieni P; Robbins HA
87,"Blom EF, Haaf T, De Koning K, HJ. Trends in lung cancer risk and screening eligibility affect overdiagnosis estimates. Lung Cancer. 2020;139.",Trends in lung cancer risk and screening eligibility affect overdiagnosis estimates,Lung Cancer,2020,139,,,,,Blom EF; Haaf T; De Koning K; HJ
88,"Maldonado G, Motsch S, Trotter E, A. Overdiagnosis in lung cancer screening: Estimates from the German Lung Cancer Screening Intervention Trial. Int J Cancer. 2021;148.",Overdiagnosis in lung cancer screening: Estimates from the German Lung Cancer Screening Intervention Trial,Int J Cancer,2021,148,,,,,Maldonado G; Motsch S; Trotter E; A
89,Reich JM. A critical appraisal of overdiagnosis: estimates of its magnitude and implications for lung cancer screening. Thorax. 2008;63.,A critical appraisal of overdiagnosis: estimates of its magnitude and implications for lung cancer screening,Thorax,2008,63,,,,,Reich JM
90,Black WC. Computed tomography screening for lung cancer: review of screening principles and update on current status. Cancer. 2007;110.,Computed tomography screening for lung cancer: review of screening principles and update on current status,Cancer,2007,110,,,,,Black WC
91,"Pastorino U, Silva M, Sestini S. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy. Ann Oncol. 2019;30.",Prolonged lung cancer screening reduced 10-year mortality in the MILD trial: new confirmation of lung cancer screening efficacy,Ann Oncol,2019,30,,,,,Pastorino U; Silva M; Sestini S
92,"Becker N, Motsch E, Trotter A. Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial. Int J Cancer. 2020;146.",Lung cancer mortality reduction by LDCT screening-Results from the randomized German LUSI trial,Int J Cancer,2020,146,,,,,Becker N; Motsch E; Trotter A
93,"Field JK, Vulkan D, Davies M. Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international metaanalysis. Lancet Reg Health Eur. 2021;10:100179.",Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international metaanalysis,Lancet Reg Health Eur,2021,10,,100179,,,Field JK; Vulkan D; Davies M
94,"Jonas DE, Reuland DS, Reddy SM. Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2021;325.",Screening for Lung Cancer With Low-Dose Computed Tomography: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force,JAMA,2021,325,,,,,Jonas DE; Reuland DS; Reddy SM
95,"Wille MM, Dirksen A, Ashraf H. Results of the randomized Danish Lung Cancer Screening Trial with focus on high-risk profiling. Am J Respir Crit Care Med. 2016;193.",Results of the randomized Danish Lung Cancer Screening Trial with focus on high-risk profiling,Am J Respir Crit Care Med,2016,193,,,,,Wille MM; Dirksen A; Ashraf H
96,"Horeweg N, Van Rosmalen J, Heuvelmans MA. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Screening for Lung Cancer with Low Dose Computed Tomography (LDCT). CAG-00439R: Centers for Medicare and Medicaid Services (CMS). 2012;15.",Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening,Screening for Lung Cancer with Low Dose Computed Tomography (LDCT). CAG-00439R: Centers for Medicare and Medicaid Services (CMS),2012,15,,,,,Horeweg N; Van Rosmalen J; Heuvelmans MA
97,"Meza R, Jeon J, Toumazis I. Evaluation of the benefits and harms of lung cancer screening with low-dose computed tomography: Modeling study for the US Preventive Services Task Force. JAMA. 2021;325.",Evaluation of the benefits and harms of lung cancer screening with low-dose computed tomography: Modeling study for the US Preventive Services Task Force,JAMA,2021,325,,,,,Meza R; Jeon J; Toumazis I
98,"Labaki WW, Xia M, Murray S. Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. J Thorac Oncol. 2008;159.","Epidemiology of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines",J Thorac Oncol,2008,159,,,,,Labaki WW; Xia M; Murray S
99,"Darby S, Hill D, Auvinen A. Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European casecontrol studies. J Natl Cancer Inst. 2002;330:7380.",Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European casecontrol studies,J Natl Cancer Inst,2002,330,,7380,,,Darby S; Hill D; Auvinen A
100,"Driscoll T, Nelson DI, Steenland K. The value and process of inclusion: Using sensitive, respectful, and inclusive language and images in NCCN content. J Natl Compr Canc Netw. 2005;48.","The value and process of inclusion: Using sensitive, respectful, and inclusive language and images in NCCN content",J Natl Compr Canc Netw,2005,48,,,,,Driscoll T; Nelson DI; Steenland K
101,"De Groot P, Munden RF, Hill R, Rj A. Genetic risk can be decreased: Quitting smoking decreases and delays lung cancer for smokers with high and low CHRNA5 risk genotypes -A meta-analysis. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. 1950;50.",Genetic risk can be decreased: Quitting smoking decreases and delays lung cancer for smokers with high and low CHRNA5 risk genotypes -A meta-analysis,The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General,1950,50,,,,,De Groot P; Munden RF; Hill R; Rj A
102,"Secretan B, Straif K, Baan R. What proportion of cancer deaths in the contemporary United States is attributable to cigarette smoking?. Int J Mol Epidemiol Genet. 2009;10(Suppl 5).",What proportion of cancer deaths in the contemporary United States is attributable to cigarette smoking?,Int J Mol Epidemiol Genet,2009,10,Suppl 5,,,,Secretan B; Straif K; Baan R
103,"Safiri S, Nejadghaderi SA, Abdollahi M. Global, regional, and national burden of cancers attributable to tobacco smoking in 204 countries and territories, 1990-2019. Cancer Med. 2022;11:131.","Global, regional, and national burden of cancers attributable to tobacco smoking in 204 countries and territories, 1990-2019",Cancer Med,2022,11,,131,,,Safiri S; Nejadghaderi SA; Abdollahi M
104,"Centers For Disease C, P. Smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 2000-2004. MMWR Morb Mortal Wkly Rep. 2008;57.","Smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 2000-2004",MMWR Morb Mortal Wkly Rep,2008,57,,,,,Centers For Disease C; P
105,"Jha P, Ramasundarahettige C, Landsman V. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013;368.",21st-century hazards of smoking and benefits of cessation in the United States,N Engl J Med,2013,368,,,,,Jha P; Ramasundarahettige C; Landsman V
106,"Doll R, Peto R, Boreham J, Sutherland I, Holford TR, Levy DT. Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000. J Natl Cancer Inst. 2004;328.",Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000,J Natl Cancer Inst,2004,328,,,,,Doll R; Peto R; Boreham J; Sutherland I; Holford TR; Levy DT
107,"Peto R, Darby S, Deo H. Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies. BMJ. 2000;321.","Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies",BMJ,2000,321,,,,,Peto R; Darby S; Deo H
108,"Tindle HA, Duncan S, Greevy M, RA. Lung cancer risk reduction after smoking cessation: observations from a prospective cohort of women. J Natl Cancer Inst. 2003;110.",Lung cancer risk reduction after smoking cessation: observations from a prospective cohort of women,J Natl Cancer Inst,2003,110,,,,,Tindle HA; Duncan S; Greevy M; RA
109,"Yang P, Wang Y, Wampfler JA. Tobacco-product use by adults and youths in the United States in 2013 and 2014. Tobacco Control Monograph 9: Cigars: Health Effects and Trends. 1998;11.",Tobacco-product use by adults and youths in the United States in 2013 and 2014,Tobacco Control Monograph 9: Cigars: Health Effects and Trends,1998,11,,,,,Yang P; Wang Y; Wampfler JA
110,Garfinkel L. Time trends in lung cancer mortality among nonsmokers and a note on passive smoking. Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General. 1981;66:147.,Time trends in lung cancer mortality among nonsmokers and a note on passive smoking,Consequences of Involuntary Exposure to Tobacco Smoke: A Report of the Surgeon General,1981,66,,147,,,Garfinkel L
111,"Hackshaw AK, Law MR, Wald NJ. The accumulated evidence on lung cancer and environmental tobacco smoke. BMJ. 1997;315.",The accumulated evidence on lung cancer and environmental tobacco smoke,BMJ,1997,315,,,,,Hackshaw AK; Law MR; Wald NJ
112,"Loomis D, Guha N, Hall AL, Straif K, Margery J, Laurent F. Medical follow-up of workers exposed to lung carcinogens: French evidence-based and pragmatic recommendations. Occup Environ Med. 2017;75:191.",Medical follow-up of workers exposed to lung carcinogens: French evidence-based and pragmatic recommendations,Occup Environ Med,2017,75,,191,,,Loomis D; Guha N; Hall AL; Straif K; Margery J; Laurent F
113,"Straif K, Benbrahim-Tallaa L, Baan R. A review of human carcinogens--Part C: metals, arsenic, dusts, and fibres. Lancet Oncol. 2009;10.","A review of human carcinogens--Part C: metals, arsenic, dusts, and fibres",Lancet Oncol,2009,10,,,,,Straif K; Benbrahim-Tallaa L; Baan R
114,"Silverman DT, Samanic CM, Lubin JH. The Diesel Exhaust in Miners study: a nested case-control study of lung cancer and diesel exhaust. J Natl Cancer Inst. 2012;104.",The Diesel Exhaust in Miners study: a nested case-control study of lung cancer and diesel exhaust,J Natl Cancer Inst,2012,104,,,,,Silverman DT; Samanic CM; Lubin JH
115,"Nelson DI, Barrientos C-, Driscoll M, T. The global burden of selected occupational diseases and injury risks: Methodology and summary. Am J Ind Med. 2005;48.",The global burden of selected occupational diseases and injury risks: Methodology and summary,Am J Ind Med,2005,48,,,,,Nelson DI; Barrientos C-; Driscoll M; T
116,"Nurminen M, Karjalainen A, Loomis K et al.. Radon, smoking and lung cancer risk: results of a joint analysis of three European case-control studies among uranium miners. Scand J Work Environ Health. 1996;27.","Radon, smoking and lung cancer risk: results of a joint analysis of three European case-control studies among uranium miners",Scand J Work Environ Health,1996,27,,,,,Nurminen M; Karjalainen A; Loomis K; Shy D; Simonsen C; Harrison N; Laurier JD; D
117,"Wu GX, Nelson RA, Kim JY, Raz D, Murray N, Shaw EG. Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre. J Natl Cancer Inst. 1997;18.",Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre,J Natl Cancer Inst,1997,18,,,,,Wu GX; Nelson RA; Kim JY; Raz D; Murray N; Shaw EG
118,"Luo SJ, Choi E, Aredo JV. Smoking cessation after lung cancer diagnosis and the risk of second primary lung cancer: The multiethnic cohort study. JNCI Cancer Spectr. 2021;5.",Smoking cessation after lung cancer diagnosis and the risk of second primary lung cancer: The multiethnic cohort study,JNCI Cancer Spectr,2021,5,,,,,Luo SJ; Choi E; Aredo JV
119,"Shiels MS, Gibson T, Sampson J. Cigarette smoking prior to first cancer and risk of second smoking-associated cancers among survivors of bladder, kidney, head and neck, and stage I lung cancers. J Clin Oncol. 2014;32.","Cigarette smoking prior to first cancer and risk of second smoking-associated cancers among survivors of bladder, kidney, head and neck, and stage I lung cancers",J Clin Oncol,2014,32,,,,,Shiels MS; Gibson T; Sampson J
120,"Spector JG, Sessions DG, Haughey BH. Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer. Jpn J Clin Oncol. 1993;111.",Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer,Jpn J Clin Oncol,1993,111,,,,,Spector JG; Sessions DG; Haughey BH
121,"Amos CI, Wu X, Broderick P. The 15q24/25 susceptibility variant for lung cancer and chronic obstructive pulmonary disease is with emphysema. Am J Respir Crit Care Med. 2008;40.",The 15q24/25 susceptibility variant for lung cancer and chronic obstructive pulmonary disease is with emphysema,Am J Respir Crit Care Med,2008,40,,,,,Amos CI; Wu X; Broderick P
122,"Hwang SJ, Cheng LS, Lozano G. Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk. Br J Cancer. 1989;113.","Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk",Br J Cancer,1989,113,,,,,Hwang SJ; Cheng LS; Lozano G
123,"Fletcher O, Easton D, Anderson K. Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. J Natl Cancer Inst. 1986;96:1097.","Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk",J Natl Cancer Inst,1986,96,,1097,,,Fletcher O; Easton D; Anderson K
124,"Hopkins RJ, Duan F, Chiles C. Reduced expiratory flow rate among heavy smokers increases lung cancer risk. Results from the National Lung Screening Trial-American College of Radiology Imaging Network Cohort. Ann Am Thorac Soc. 2017;14.",Reduced expiratory flow rate among heavy smokers increases lung cancer risk. Results from the National Lung Screening Trial-American College of Radiology Imaging Network Cohort,Ann Am Thorac Soc,2017,14,,,,,Hopkins RJ; Duan F; Chiles C
125,"Young RP, Hopkins RJ, Gazelle GS, Gilmore ME. Genetic predisposition to chronic obstructive pulmonary disease and/or lung cancer: important considerations when evaluating risk. Cancer Prev Res (Phila). 2009;7.",Genetic predisposition to chronic obstructive pulmonary disease and/or lung cancer: important considerations when evaluating risk,Cancer Prev Res (Phila),2009,7,,,,,Young RP; Hopkins RJ; Gazelle GS; Gilmore ME
126,"Turner MC, Chen Y, Krewski D. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med. 1980;176.",Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers,Am J Respir Crit Care Med,1980,176,,,,,Turner MC; Chen Y; Krewski D
127,"Hubbard R, Venn A, Lewis S et al.. Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial. Am J Respir Crit Care Med. 1991;161.",Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial,Am J Respir Crit Care Med,1991,161,,,,,Hubbard R; Venn A; Lewis S; Britton J; Jm; Weill H; Ag; Wakelee H
128,"Jaklitsch MT, Jacobson FL, Austin JH. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg. 2012;144.",The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups,J Thorac Cardiovasc Surg,2012,144,,,,,Jaklitsch MT; Jacobson FL; Austin JH
129,"Mckee BJ, Hashim JA, French RJ. Experience with a CT screening program for individuals at high risk for developing lung cancer. J Am Coll Radiol. 2015;12.",Experience with a CT screening program for individuals at high risk for developing lung cancer,J Am Coll Radiol,2015,12,,,,,Mckee BJ; Hashim JA; French RJ
130,"Katki HA, Kovalchik SA, Berg CD. Community-based multidisciplinary computed tomography screening program improves lung cancer survival. Ann Thorac Surg. 2016;315.",Community-based multidisciplinary computed tomography screening program improves lung cancer survival,Ann Thorac Surg,2016,315,,,,,Katki HA; Kovalchik SA; Berg CD
131,"Li K, Husing A, Sookthai D. Selecting high-risk individuals for lung cancer screening: A prospective evaluation of existing risk models and eligibility criteria in the German EPIC cohort. Cancer Prev Res (Phila). 2015;8.",Selecting high-risk individuals for lung cancer screening: A prospective evaluation of existing risk models and eligibility criteria in the German EPIC cohort,Cancer Prev Res (Phila),2015,8,,,,,Li K; Husing A; Sookthai D
132,"Wood DE, Kazerooni E, Aberle D. NCCN Clinical Practice Guidelines In Oncology (NCCN Guidelines®) for Lung Cancer Screening: Version 1.2021 © 2020. NCCN Clinical Practice Guidelines In Oncology (NCCN Guidelines®) for Lung Cancer Screening: Version 1.2021 © 2020. None;None.",NCCN Clinical Practice Guidelines In Oncology (NCCN Guidelines®) for Lung Cancer Screening: Version 1.2021 © 2020,NCCN Clinical Practice Guidelines In Oncology (NCCN Guidelines®) for Lung Cancer Screening: Version 1.2021 © 2020,,,,,,,Wood DE; Kazerooni E; Aberle D
133,"Pastorino U, Sverzellati N, Sestini S. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT. J Natl Cancer Inst. 2005;118.",CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT,J Natl Cancer Inst,2005,118,,,,,Pastorino U; Sverzellati N; Sestini S
134,"Wilson DO, Weissfeld JL, Fuhrman CR. The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan. Am J Respir Crit Care Med. 2008;178.",The Pittsburgh Lung Screening Study (PLuSS): outcomes within 3 years of a first computed tomography scan,Am J Respir Crit Care Med,2008,178,,,,,Wilson DO; Weissfeld JL; Fuhrman CR
135,"Aldrich MC, Mercaldo SF, Sandler KL. Evaluation of USPSTF lung cancer screening guidelines among African American adult smokers. JAMA Oncol. 2019;5.",Evaluation of USPSTF lung cancer screening guidelines among African American adult smokers,JAMA Oncol,2019,5,,,,,Aldrich MC; Mercaldo SF; Sandler KL
136,"Pasquinelli MM, Tammemagi MC, Kovitz KL. Risk prediction model versus United States Preventive Services Task Force Lung Cancer Screening Eligibility Criteria: Reducing race disparities. J Thorac Oncol. 2020;15.",Risk prediction model versus United States Preventive Services Task Force Lung Cancer Screening Eligibility Criteria: Reducing race disparities,J Thorac Oncol,2020,15,,,,,Pasquinelli MM; Tammemagi MC; Kovitz KL
137,"Williams RM, Li T, Luta G. Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data. Cancer. 2022;128.",Lung cancer screening use and implications of varying eligibility criteria by race and ethnicity: 2019 Behavioral Risk Factor Surveillance System data,Cancer,2022,128,,,,,Williams RM; Li T; Luta G
138,"Kavanagh J, Liu G, Menezes R. Development and validation of a multivariable lung cancer risk prediction model that includes low-dose computed tomography screening results: A secondary analysis of data from the National Lung Screening Trial. JAMA Netw Open. 2018;289:e190204.",Development and validation of a multivariable lung cancer risk prediction model that includes low-dose computed tomography screening results: A secondary analysis of data from the National Lung Screening Trial,JAMA Netw Open,2018,289,,e190204,,,Kavanagh J; Liu G; Menezes R
139,"Pinsky PF, Gierada DS, Hocking W. Occurrence and lung cancer probability of new solid nodules at incidence screening with lowdose CT: analysis of data from the randomised, controlled NELSON trial. Ann Intern Med. 2011;161.","Occurrence and lung cancer probability of new solid nodules at incidence screening with lowdose CT: analysis of data from the randomised, controlled NELSON trial",Ann Intern Med,2011,161,,,,,Pinsky PF; Gierada DS; Hocking W
140,"Meza R, Jeon J, Toumazis I. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: A Collaborative Modeling Study for the U. JAMA. 2012;307.","Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews. Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: A Collaborative Modeling Study for the U",JAMA,2012,307,,,,,Meza R; Jeon J; Toumazis I
141,"De Gonzalez B, Kim A, Berg KP et al.. Low-dose lung computed tomography screening before age 55: estimates of the mortality reduction required to outweigh the radiation-induced cancer risk. AJR Am J Roentgenol. 2008;15(Suppl 5).",Low-dose lung computed tomography screening before age 55: estimates of the mortality reduction required to outweigh the radiation-induced cancer risk,AJR Am J Roentgenol,2008,15,Suppl 5,,,,De Gonzalez B; Kim A; Berg KP; Sc C; Hammer M; Bowman RV; Yang IA
142,"Yip R, Henschke CI, Xu DM. Lung cancers manifesting as partsolid nodules in the National Lung Screening Trial. AJR Am J Roentgenol. 2014;208.",Lung cancers manifesting as partsolid nodules in the National Lung Screening Trial,AJR Am J Roentgenol,2014,208,,,,,Yip R; Henschke CI; Xu DM
143,"Naidich DP, Bankier AA, Macmahon H. The IASLC Lung Cancer Staging Project: Proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth edition of the TNM Classification of Lung Cancer. Arch Pathol Lab Med. 2007;266.",The IASLC Lung Cancer Staging Project: Proposals for coding T categories for subsolid nodules and assessment of tumor size in part-solid tumors in the forthcoming eighth edition of the TNM Classification of Lung Cancer,Arch Pathol Lab Med,2007,266,,,,,Naidich DP; Bankier AA; Macmahon H
144,"Macmahon H, Naidich DP, Goo JM. Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers. Radiology. 2007;284.","Five-year lung cancer screening experience: CT appearance, growth rate, location, and histologic features of 61 lung cancers",Radiology,2007,284,,,,,Macmahon H; Naidich DP; Goo JM
145,"Henschke CI, Yip R, Smith JP. CT screening for lung cancer: Part-solid nodules in baseline and annual repeat rounds. AJR Am J Roentgenol. 2016;207.",CT screening for lung cancer: Part-solid nodules in baseline and annual repeat rounds,AJR Am J Roentgenol,2016,207,,,,,Henschke CI; Yip R; Smith JP
146,"Walter JE, Heuvelmans MA, Bock GH. Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study. Thorax. 2018;73.",Characteristics of new solid nodules detected in incidence screening rounds of low-dose CT lung cancer screening: the NELSON study,Thorax,2018,73,,,,,Walter JE; Heuvelmans MA; Bock GH
147,"Mcwilliams A, Tammemagi MC, Mayo JR. A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules. AJR Am J Roentgenol. 2006;369.",A comparison of the diagnostic accuracy of 18F-FDG PET and CT in the characterization of solitary pulmonary nodules,AJR Am J Roentgenol,2006,369,,,,,Mcwilliams A; Tammemagi MC; Mayo JR
148,"Kim H, Park CM, Koh JM. Pulmonary subsolid nodules: what radiologists need to know about the imaging features and management strategy. Diagn Interv Radiol. 2014;20.",Pulmonary subsolid nodules: what radiologists need to know about the imaging features and management strategy,Diagn Interv Radiol,2014,20,,,,,Kim H; Park CM; Koh JM
149,"Patel VK, Naik SK, Naidich DP. A practical algorithmic approach to the diagnosis and management of solitary pulmonary nodules: part 2: pretest probability and algorithm. Radiology. 2013;143.",A practical algorithmic approach to the diagnosis and management of solitary pulmonary nodules: part 2: pretest probability and algorithm,Radiology,2013,143,,,,,Patel VK; Naik SK; Naidich DP
150,"Kakinuma R, Muramatsu Y, Kusumoto M. Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based NCCN Guidelines Version 2.2024 Lung Cancer Screening MS-47 clinical practice guidelines (2nd edition). Eur J Nucl Med Mol Imaging. 2005;276:27.",Evaluation of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based NCCN Guidelines Version 2.2024 Lung Cancer Screening MS-47 clinical practice guidelines (2nd edition),Eur J Nucl Med Mol Imaging,2005,276,,27,,,Kakinuma R; Muramatsu Y; Kusumoto M
151,"Sebro R, Aparici CM, Hernandez-Pampaloni M. FDG PET/CT evaluation of pathologically proven pulmonary lesions in an area of high endemic granulomatous disease. Ann Nucl Med. 2013;27.",FDG PET/CT evaluation of pathologically proven pulmonary lesions in an area of high endemic granulomatous disease,Ann Nucl Med,2013,27,,,,,Sebro R; Aparici CM; Hernandez-Pampaloni M
152,"Reyes N, Onadeko OO, Mdel L, C. Positron emission tomography in the evaluation of pulmonary nodules among patients living in a coccidioidal endemic region. Lung. 2014;192.",Positron emission tomography in the evaluation of pulmonary nodules among patients living in a coccidioidal endemic region,Lung,2014,192,,,,,Reyes N; Onadeko OO; Mdel L; C
153,"Huber H, Hodolic M, Stelzmuller I. Malignant disease as an incidental finding at (1)(8)F-FDG-PET/CT scanning in patients with granulomatous lung disease. Nucl Med Commun. 2015;36.",Malignant disease as an incidental finding at (1)(8)F-FDG-PET/CT scanning in patients with granulomatous lung disease,Nucl Med Commun,2015,36,,,,,Huber H; Hodolic M; Stelzmuller I
154,"Tammemagi MC, Schmidt H, Martel S. Value of axial and coronal maximum intensity projection (MIP) images in the detection of pulmonary nodules by multislice spiral CT: comparison with axial 1-mm and 5-mm slices. J Am Coll Radiol. 2006;18.",Value of axial and coronal maximum intensity projection (MIP) images in the detection of pulmonary nodules by multislice spiral CT: comparison with axial 1-mm and 5-mm slices,J Am Coll Radiol,2006,18,,,,,Tammemagi MC; Schmidt H; Martel S
155,"Fischbach F, Knollmann F, Griesshaber V. Detection of pulmonary nodules by multislice computed tomography: improved detection rate with reduced slice thickness. Eur Radiol. 2003;13.",Detection of pulmonary nodules by multislice computed tomography: improved detection rate with reduced slice thickness,Eur Radiol,2003,13,,,,,Fischbach F; Knollmann F; Griesshaber V
156,"Kawel N, Seifert B, Luetolf M, Boehm T, Sailer J, Weber M. Efficacy of computer-aided detection system and thin-slab maximum intensity projection technique in the detection of pulmonary nodules in patients with resected metastases. AJR Am J Roentgenol. 2007;192.",Efficacy of computer-aided detection system and thin-slab maximum intensity projection technique in the detection of pulmonary nodules in patients with resected metastases,AJR Am J Roentgenol,2007,192,,,,,Kawel N; Seifert B; Luetolf M; Boehm T; Sailer J; Weber M
157,"Jankowski A, Martinelli T, Timsit JF. Pulmonary nodule detection on MDCT images: evaluation of diagnostic performance using thin axial images, maximum intensity projections, and computer-assisted detection. Eur Radiol. 2007;17.","Pulmonary nodule detection on MDCT images: evaluation of diagnostic performance using thin axial images, maximum intensity projections, and computer-assisted detection",Eur Radiol,2007,17,,,,,Jankowski A; Martinelli T; Timsit JF
158,"Rubin GD, Lyo JK, Paik DS. Pulmonary nodules on multidetector row CT scans: performance comparison of radiologists and computer-aided detection. Radiology. 2005;234.",Pulmonary nodules on multidetector row CT scans: performance comparison of radiologists and computer-aided detection,Radiology,2005,234,,,,,Rubin GD; Lyo JK; Paik DS
159,"Fraioli F, Bertoletti L, Napoli A. Computer-aided detection (CAD) in lung cancer screening at chest MDCT: ROC analysis of CAD versus radiologist performance. J Thorac Imaging. 2007;22.",Computer-aided detection (CAD) in lung cancer screening at chest MDCT: ROC analysis of CAD versus radiologist performance,J Thorac Imaging,2007,22,,,,,Fraioli F; Bertoletti L; Napoli A
160,"Sahiner B, Chan HP, Hadjiiski LM. Performance evaluation of a computer-aided detection algorithm for solid pulmonary nodules in lowdose and standard-dose MDCT chest examinations and its influence on radiologists. BMI Classification Percentile And Cut Off Points. 2008;16:20170405.",Performance evaluation of a computer-aided detection algorithm for solid pulmonary nodules in lowdose and standard-dose MDCT chest examinations and its influence on radiologists,BMI Classification Percentile And Cut Off Points,2008,16,,20170405,,,Sahiner B; Chan HP; Hadjiiski LM
161,"Van Riel SJ, Sanchez CI, Bankier AA. Differentiating between subsolid and solid pulmonary nodules at CT: Inter-and intraobserver agreement between experienced thoracic radiologists. Radiology. 2015;277.",Differentiating between subsolid and solid pulmonary nodules at CT: Inter-and intraobserver agreement between experienced thoracic radiologists,Radiology,2015,277,,,,,Van Riel SJ; Sanchez CI; Bankier AA
162,"Kim H, Park CM, Song YS. Measurement variability of persistent pulmonary subsolid nodules on same-day repeat CT: What is the threshold to determine true nodule growth during follow-up?. PLoS One. 2016;11:148853.",Measurement variability of persistent pulmonary subsolid nodules on same-day repeat CT: What is the threshold to determine true nodule growth during follow-up?,PLoS One,2016,11,,148853,,,Kim H; Park CM; Song YS
163,"Penn A, Ma M, Chou BB. Inter-reader variability when applying the 2013 Fleischner guidelines for potential solitary subsolid lung nodules. Acta Radiol. 2013;56.",Inter-reader variability when applying the 2013 Fleischner guidelines for potential solitary subsolid lung nodules,Acta Radiol,2013,56,,,,,Penn A; Ma M; Chou BB
164,"Singh S, Pinsky P, Fineberg NS. Evaluation of reader variability in the interpretation of follow-up CT scans at lung cancer screening. Radiology. 2008;259.",Evaluation of reader variability in the interpretation of follow-up CT scans at lung cancer screening,Radiology,2008,259,,,,,Singh S; Pinsky P; Fineberg NS
165,"Hein PA, Romano VC, Rogalla P. Linear and volume measurements of pulmonary nodules at different CT dose levels -intrascan and interscan analysis. Rofo. 2009;181.",Linear and volume measurements of pulmonary nodules at different CT dose levels -intrascan and interscan analysis,Rofo,2009,181,,,,,Hein PA; Romano VC; Rogalla P
166,"Demb J, Chu P, Yu S. Presence of local pleural adhesion in CT screening-detected small nodule in the lung periphery suggests noncancerous, inflammatory nature of the lesion. J Thorac Imaging. 2007;179.","Presence of local pleural adhesion in CT screening-detected small nodule in the lung periphery suggests noncancerous, inflammatory nature of the lesion",J Thorac Imaging,2007,179,,,,,Demb J; Chu P; Yu S
167,"Xu DM, Van Der Zaag-Loonen HJ, Oudkerk M. Smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON study: cancer risk during 1 year of follow-up. Eur Radiol. 2009;250.",Smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON study: cancer risk during 1 year of follow-up,Eur Radiol,2009,250,,,,,Xu DM; Van Der Zaag-Loonen HJ; Oudkerk M
168,"Horeweg N, Van Der Aalst CM, Thunnissen E. Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial. Am J Respir Crit Care Med. 2013;187.",Characteristics of lung cancers detected by computer tomography screening in the randomized NELSON trial,Am J Respir Crit Care Med,2013,187,,,,,Horeweg N; Van Der Aalst CM; Thunnissen E
169,"Van Klaveren RJ, Oudkerk M, Prokop M. Management of lung nodules detected by volume CT scanning. N Engl J Med. 2009;361.",Management of lung nodules detected by volume CT scanning,N Engl J Med,2009,361,,,,,Van Klaveren RJ; Oudkerk M; Prokop M
170,"Hecht HS, Cronin P, Blaha MJ. SCCT/STR guidelines for coronary artery calcium scoring of noncontrast noncardiac chest CT scans: A report of the Society of Cardiovascular Computed Tomography and Society of Thoracic Radiology. J Thorac Imaging. 2016;32.",SCCT/STR guidelines for coronary artery calcium scoring of noncontrast noncardiac chest CT scans: A report of the Society of Cardiovascular Computed Tomography and Society of Thoracic Radiology,J Thorac Imaging,2016,32,,,,,Hecht HS; Cronin P; Blaha MJ
171,"Hecht HS, Cronin P, Blaha MJ. Erratum to ""2016 SCCT/STR guidelines for coronary artery calcium scoring of noncontrast noncardiac chest CT scans a report of the society of Cardiovascular Computed Tomography and Society of Thoracic Radiology. J. Cardiovasc. Comput. Tomogr. 2010;11.","Erratum to ""2016 SCCT/STR guidelines for coronary artery calcium scoring of noncontrast noncardiac chest CT scans a report of the society of Cardiovascular Computed Tomography and Society of Thoracic Radiology",J. Cardiovasc. Comput. Tomogr,2010,11,,,,,Hecht HS; Cronin P; Blaha MJ
172,"Christner JA, Kofler JM, Mccollough CH, Boffetta P, Gorlova O. Estimating effective dose for CT using dose-length product compared with using organ doses: consequences of adopting International Commission on Radiological Protection publication 103 or dual-energy scanning. recruitment and baseline results of the ITALUNG trial for lung cancer screening with. 2009;194.",Estimating effective dose for CT using dose-length product compared with using organ doses: consequences of adopting International Commission on Radiological Protection publication 103 or dual-energy scanning,recruitment and baseline results of the ITALUNG trial for lung cancer screening with,2009,194,,,,,Christner JA; Kofler JM; Mccollough CH; Boffetta P; Gorlova O
173,"Veronesi G, Bellomi M, Scanagatta P. Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program. J Thorac Cardiovasc Surg. 2008;136.",Difficulties encountered managing nodules detected during a computed tomography lung cancer screening program,J Thorac Cardiovasc Surg,2008,136,,,,,Veronesi G; Bellomi M; Scanagatta P
174,"Infante M, Cavuto S, Lutman FR. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial. Am J Respir Crit Care Med. 2009;180.",A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial,Am J Respir Crit Care Med,2009,180,,,,,Infante M; Cavuto S; Lutman FR
175,"Swensen SJ, Jett JR, Hartman TE. Lung cancer screening with CT: Mayo Clinic experience. Radiology. 2003;226.",Lung cancer screening with CT: Mayo Clinic experience,Radiology,2003,226,,,,,Swensen SJ; Jett JR; Hartman TE
176,"Henschke CI, Yankelevitz DF, Naidich DP. CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans. Radiology. 2004;231.",CT screening for lung cancer: suspiciousness of nodules according to size on baseline scans,Radiology,2004,231,,,,,Henschke CI; Yankelevitz DF; Naidich DP
177,"Henschke CI, Yankelevitz DF, Miettinen OS et al.. Computed tomographic screening for lung cancer: the relationship of disease stage to tumor size. Arch Intern Med. 2006;166.",Computed tomographic screening for lung cancer: the relationship of disease stage to tumor size,Arch Intern Med,2006,166,,,,,Henschke CI; Yankelevitz DF; Miettinen OS; Early I; Cancer L; Program A; Henschke I; Yankelevitz CI; DF
178,"Steele JD, Buell P. Asymptomatic solitary pulmonary nodules. Host survival, tumor size, and growth rate. J Thorac Cardiovasc Surg. 1973;65.","Asymptomatic solitary pulmonary nodules. Host survival, tumor size, and growth rate",J Thorac Cardiovasc Surg,1973,65,,,,,Steele JD; Buell P
179,"Galante E, Reduzzi D, Gallus G. The growth rate in the interpretation of the natural history of lung cancer. Tumori. 1984;70.",The growth rate in the interpretation of the natural history of lung cancer,Tumori,1984,70,,,,,Galante E; Reduzzi D; Gallus G
180,"Usuda K, Saito Y, Sagawa M. Combined contrastenhanced computed tomography and 18-fluoro-2-deoxy-D-glucosepositron emission tomography in the diagnosis and staging of non-small cell lung cancer. Semin Thorac Cardiovasc Surg. 1970;74.",Combined contrastenhanced computed tomography and 18-fluoro-2-deoxy-D-glucosepositron emission tomography in the diagnosis and staging of non-small cell lung cancer,Semin Thorac Cardiovasc Surg,1970,74,,,,,Usuda K; Saito Y; Sagawa M
181,"Bastarrika G, Garcia-Velloso MJ, Lozano MD. Early lung cancer detection using spiral computed tomography and positron emission tomography. Am J Respir Crit Care Med. 2005;171.",Early lung cancer detection using spiral computed tomography and positron emission tomography,Am J Respir Crit Care Med,2005,171,,,,,Bastarrika G; Garcia-Velloso MJ; Lozano MD
182,"Ashraf H, Dirksen A, Loft A. Combined use of positron emission tomography and volume doubling time in lung cancer screening with lowdose CT scanning. Thorax. 2011;66.",Combined use of positron emission tomography and volume doubling time in lung cancer screening with lowdose CT scanning,Thorax,2011,66,,,,,Ashraf H; Dirksen A; Loft A
183,"Ohno Y, Koyama H, Matsumoto K. Differentiation of malignant and benign pulmonary nodules with quantitative first-pass 320-detector row perfusion CT versus FDG PET/CT. Radiology. 2011;258.",Differentiation of malignant and benign pulmonary nodules with quantitative first-pass 320-detector row perfusion CT versus FDG PET/CT,Radiology,2011,258,,,,,Ohno Y; Koyama H; Matsumoto K
184,"Henschke CI, Yankelevitz DF, Jirapatnakul A. Implementation of low-dose CT screening in two different health care systems: Mount Sinai Healthcare System and Phoenix VA Health Care System. Transl Lung Cancer Res. 2021;10.",Implementation of low-dose CT screening in two different health care systems: Mount Sinai Healthcare System and Phoenix VA Health Care System,Transl Lung Cancer Res,2021,10,,,,,Henschke CI; Yankelevitz DF; Jirapatnakul A
185,"Henschke CI, Yip R, Shaham D. The regimen of computed tomography screening for lung cancer: Lessons learned over 25 years from the International Early Lung Cancer Action Program. J Thorac Imaging. 2021;36.",The regimen of computed tomography screening for lung cancer: Lessons learned over 25 years from the International Early Lung Cancer Action Program,J Thorac Imaging,2021,36,,,,,Henschke CI; Yip R; Shaham D
186,"Gierada DS, Pinsky P, Nath H. Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination. J Natl Cancer Inst. 2014;106.",Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination,J Natl Cancer Inst,2014,106,,,,,Gierada DS; Pinsky P; Nath H
187,"Yip R, Henschke CI, Yankelevitz DF, Smith J, Kazerooni E, Baum SL. CT screening for lung cancer: alternative definitions of positive test result based on the national lung screening trial and international early lung cancer action program databases. J Natl Compr Canc Netw. 2014;273.",CT screening for lung cancer: alternative definitions of positive test result based on the national lung screening trial and international early lung cancer action program databases,J Natl Compr Canc Netw,2014,273,,,,,Yip R; Henschke CI; Yankelevitz DF; Smith J; Kazerooni E; Baum SL
188,"Macmahon H, Austin JH, Gamsu G. Updated Fleischner Society Guidelines for managing incidental pulmonary nodules: Common questions and challenging scenarios. J Am Coll Radiol. 2005;237.",Updated Fleischner Society Guidelines for managing incidental pulmonary nodules: Common questions and challenging scenarios,J Am Coll Radiol,2005,237,,,,,Macmahon H; Austin JH; Gamsu G
189,"Henschke CI, Yip R, Yankelevitz DF. Definition of a positive test result in computed tomography screening for lung cancer: a cohort study. J Am MS-53 Coll Radiol. 2012;158.",Definition of a positive test result in computed tomography screening for lung cancer: a cohort study,J Am MS-53 Coll Radiol,2012,158,,,,,Henschke CI; Yip R; Yankelevitz DF
190,"Ray CE, Mohammed T, Bienvenu M. Special treatment issues in non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. J Thorac Imaging. 2004;27.","Special treatment issues in non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines",J Thorac Imaging,2004,27,,,,,Ray CE; Mohammed T; Bienvenu M
191,"Mazzone PJ, Silvestri GA, Patel S. Overdiagnosis during lung cancer screening: is it an overemphasised, underappreciated, or tangential issue. Thorax. 2014;153.","Overdiagnosis during lung cancer screening: is it an overemphasised, underappreciated, or tangential issue",Thorax,2014,153,,,,,Mazzone PJ; Silvestri GA; Patel S
192,"Huo J, Xu Y, Sheu T. Complication rates and downstream medical costs associated with invasive diagnostic procedures for lung abnormalities in the community setting. JAMA Intern Med. 2019;179.",Complication rates and downstream medical costs associated with invasive diagnostic procedures for lung abnormalities in the community setting,JAMA Intern Med,2019,179,,,,,Huo J; Xu Y; Sheu T
193,"Yang S, Shih YT, Huo J. Total and out-of-pocket costs of procedures after lung cancer screening in a national commercially insured population: Estimating an episode of care. J Am Coll Radiol. 2014;165.",Total and out-of-pocket costs of procedures after lung cancer screening in a national commercially insured population: Estimating an episode of care,J Am Coll Radiol,2014,165,,,,,Yang S; Shih YT; Huo J
194,"Yip R, Jirapatnakul A, Hu M. Added benefits of early detection of other diseases on low-dose CT screening. Transl Lung Cancer Res. 2021;10.",Added benefits of early detection of other diseases on low-dose CT screening,Transl Lung Cancer Res,2021,10,,,,,Yip R; Jirapatnakul A; Hu M
195,"Ruparel M, Quaife SL, Dickson JL. Prevalence, symptom burden, and underdiagnosis of chronic obstructive pulmonary disease in a lung cancer screening cohort. Ann Am Thorac Soc. 2020;17.","Prevalence, symptom burden, and underdiagnosis of chronic obstructive pulmonary disease in a lung cancer screening cohort",Ann Am Thorac Soc,2020,17,,,,,Ruparel M; Quaife SL; Dickson JL
196,"Schroeder C, Drevets P, Chung JM. Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population. Am Surg Available. 2020;20:300.",Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population,Am Surg Available,2020,20,,300,,,Schroeder C; Drevets P; Chung JM
197,"Morgan L, Choi H, Reid M. Frequency of incidental findings and subsequent evaluation in low-dose computed tomographic scans for lung cancer screening. Ann Am Thorac Soc. 2017;14.",Frequency of incidental findings and subsequent evaluation in low-dose computed tomographic scans for lung cancer screening,Ann Am Thorac Soc,2017,14,,,,,Morgan L; Choi H; Reid M
198,"Goldstraw P, Crowley J, Chansky K. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. AJCC Staging Manual. 2007;2:382.",The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours,AJCC Staging Manual,2007,2,,382,,,Goldstraw P; Crowley J; Chansky K
199,"Flieder DB, Vazquez M, Carter D. Identification, biopsy, and treatment of poorly understood premalignant, in situ, and indolent low-grade cancers: are we becoming victims of our own success?. Am J Surg Pathol. 2002;30.","Identification, biopsy, and treatment of poorly understood premalignant, in situ, and indolent low-grade cancers: are we becoming victims of our own success?",Am J Surg Pathol,2002,30,,,,,Flieder DB; Vazquez M; Carter D
200,"Foy M, Yip R, Chen X. Modeling the mortality reduction due to computed tomography screening for lung cancer. J Thorac Oncol. 2011;117.",Modeling the mortality reduction due to computed tomography screening for lung cancer,J Thorac Oncol,2011,117,,,,,Foy M; Yip R; Chen X
201,"Ma J, Ward EM, Smith R, Jemal A. Annual number of lung cancer deaths potentially avertable by screening in the United States. Cancer. 2013;119.",Annual number of lung cancer deaths potentially avertable by screening in the United States,Cancer,2013,119,,,,,Ma J; Ward EM; Smith R; Jemal A
202,"Gareen IF, Duan F, Greco EM. Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial. Eur Respir J. 2011;120.",Impact of lung cancer screening results on participant health-related quality of life and state anxiety in the National Lung Screening Trial,Eur Respir J,2011,120,,,,,Gareen IF; Duan F; Greco EM
203,"Jacobs PC, Gondrie MJ, Mali WP. Unrequested information from routine diagnostic chest CT predicts future cardiovascular events. Eur Radiol. 2011;21.",Unrequested information from routine diagnostic chest CT predicts future cardiovascular events,Eur Radiol,2011,21,,,,,Jacobs PC; Gondrie MJ; Mali WP
204,"Sekikawa A, Curb JD, Edmundowicz D. Coronary artery calcification by computed tomography in epidemiologic research and cardiovascular disease prevention. J Epidemiol. 2012;22.",Coronary artery calcification by computed tomography in epidemiologic research and cardiovascular disease prevention,J Epidemiol,2012,22,,,,,Sekikawa A; Curb JD; Edmundowicz D
205,"Manser R, Wright G, Hart D. Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial. Cochrane Database Syst Rev. 2004;374:296.",Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial,Cochrane Database Syst Rev,2004,374,,296,,,Manser R; Wright G; Hart D
206,"Henschke CI, Mccauley DI, Yankelevitz DF. Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet. 1999;354.",Early Lung Cancer Action Project: overall design and findings from baseline screening,Lancet,1999,354,,,,,Henschke CI; Mccauley DI; Yankelevitz DF
207,"Sone S, Nakayama T, Honda T. Video-assisted thoracic surgery in lung cancer resection: a meta-analysis and systematic review of NCCN Guidelines Version 2.2024 Lung Cancer Screening MS-56 controlled trials. J Thorac Cardiovasc Surg. 2007;58(04).",Video-assisted thoracic surgery in lung cancer resection: a meta-analysis and systematic review of NCCN Guidelines Version 2.2024 Lung Cancer Screening MS-56 controlled trials,J Thorac Cardiovasc Surg,2007,58,04,,,,Sone S; Nakayama T; Honda T
208,"Chang JY, Li QQ, Xu QY. Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a ""no fly zone. Int J Radiat Oncol Biol Phys. 2011;88.","Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a ""no fly zone",Int J Radiat Oncol Biol Phys,2011,88,,,,,Chang JY; Li QQ; Xu QY
209,"Anderson CM, Yip R, Henschke CI. Pairing smokingcessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society. Cancer Epidemiol Biomarkers Prev. 2005;18.",Pairing smokingcessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society,Cancer Epidemiol Biomarkers Prev,2005,18,,,,,Anderson CM; Yip R; Henschke CI
210,"Cataldo JK, Dubey S, Prochaska J et al.. Long-term psychosocial outcomes of low-dose CT screening: results of the UK Lung Cancer Screening randomised controlled trial. Curr Atheroscler Rep. 2010;78.",Long-term psychosocial outcomes of low-dose CT screening: results of the UK Lung Cancer Screening randomised controlled trial,Curr Atheroscler Rep,2010,78,,,,,Cataldo JK; Dubey S; Prochaska J; Jt; Mcfadden DD; Ebbert J;; Bergh KA; Bot E; Borsboom ML; GJ
211,"Bunge EM, Van Den Bergh K, Bot E, M. High affective risk perception is associated with more lung cancer-specific distress in CT screening for lung cancer. Ann Intern Med. 2008;62.",High affective risk perception is associated with more lung cancer-specific distress in CT screening for lung cancer,Ann Intern Med,2008,62,,,,,Bunge EM; Van Den Bergh K; Bot E; M
212,"Diederich S, Wormanns D, Semik M. Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer. JAMA Intern Med. 1996;222.","Final results of the Lung Screening Study, a randomized feasibility study of spiral CT versus chest X-ray screening for lung cancer",JAMA Intern Med,1996,222,,,,,Diederich S; Wormanns D; Semik M
213,"Caverly TJ, Fagerlin A, Wiener RS. Comparison of observed harms and expected mortality benefit for persons in the Veterans Health Affairs Lung Cancer Screening Demonstration Project. Lung Cancer Screening. 2001;178:437.",Comparison of observed harms and expected mortality benefit for persons in the Veterans Health Affairs Lung Cancer Screening Demonstration Project,Lung Cancer Screening,2001,178,,437,,,Caverly TJ; Fagerlin A; Wiener RS
214,"Silvestri GA, Handy J, Lackland D. Specialists achieve better outcomes than generalists for lung cancer surgery. Chest. 1998;114.",Specialists achieve better outcomes than generalists for lung cancer surgery,Chest,1998,114,,,,,Silvestri GA; Handy J; Lackland D
215,"Stephan F, Boucheseiche S, Hollande J. Pulmonary complications following lung resection: a comprehensive analysis of incidence and possible risk factors. Chest. 2000;118.",Pulmonary complications following lung resection: a comprehensive analysis of incidence and possible risk factors,Chest,2000,118,,,,,Stephan F; Boucheseiche S; Hollande J
216,"Lillie SE, Fu SS, Fabbrini AE. What factors do patients consider most important in making lung cancer screening decisions? Findings from a demonstration project conducted in the Veterans Health Administration. Lung Cancer. 2017;104.",What factors do patients consider most important in making lung cancer screening decisions? Findings from a demonstration project conducted in the Veterans Health Administration,Lung Cancer,2017,104,,,,,Lillie SE; Fu SS; Fabbrini AE
217,"Henschke CI, Yip R, Yankelevitz DF, Miettinen OS. Computed tomography screening for lung cancer: prospects of surviving competing causes of death. Clin Lung Cancer. 2006;7.",Computed tomography screening for lung cancer: prospects of surviving competing causes of death,Clin Lung Cancer,2006,7,,,,,Henschke CI; Yip R; Yankelevitz DF; Miettinen OS
218,"Sone S, Takashima S, Li F. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet. 1998;351.",Mass screening for lung cancer with mobile spiral computed tomography scanner,Lancet,1998,351,,,,,Sone S; Takashima S; Li F
219,"Li F, Sone S, Abe H. Lung cancers missed at low-dose helical CT screening in a general population: comparison of clinical, histopathologic, and imaging findings. Radiology. 2002;225.","Lung cancers missed at low-dose helical CT screening in a general population: comparison of clinical, histopathologic, and imaging findings",Radiology,2002,225,,,,,Li F; Sone S; Abe H
220,"Armato SG, Li F, Giger ML. Lung cancer: performance of automated lung nodule detection applied to cancers missed in a CT screening program. Radiology. 2002;225.",Lung cancer: performance of automated lung nodule detection applied to cancers missed in a CT screening program,Radiology,2002,225,,,,,Armato SG; Li F; Giger ML
221,"Gierada DS, Pinsky PF, Duan F. Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification. AJR Am J Roentgenol. 2008;27.",Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification,AJR Am J Roentgenol,2008,27,,,,,Gierada DS; Pinsky PF; Duan F
222,Brenner DJ. Radiation risks potentially associated with low-dose CT screening of adult smokers for lung cancer. Radiology. 2004;231.,Radiation risks potentially associated with low-dose CT screening of adult smokers for lung cancer,Radiology,2004,231,,,,,Brenner DJ
223,"Frank L, Christodoulou E, Kazerooni EA. Radiation risk of lung cancer screening. Semin Respir Crit Care Med. 2013;34.",Radiation risk of lung cancer screening,Semin Respir Crit Care Med,2013,34,,,,,Frank L; Christodoulou E; Kazerooni EA
224,"Mascalchi M, Belli G, Zappa M. Risk-benefit analysis of X-ray exposure associated with lung cancer screening in the Italung-CT trial. AJR Am J Roentgenol. 2006;187.",Risk-benefit analysis of X-ray exposure associated with lung cancer screening in the Italung-CT trial,AJR Am J Roentgenol,2006,187,,,,,Mascalchi M; Belli G; Zappa M
225,"Goulart BH, Bensink ME, Mummy DG, Ramsey SD. Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness. J Natl Compr Canc Netw. 2012;10.","Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness",J Natl Compr Canc Netw,2012,10,,,,,Goulart BH; Bensink ME; Mummy DG; Ramsey SD
226,"Cornelius ME, Loretan CG, Wang TW. Current estimate of costs of lung cancer screening in the United States. MMWR Morb Mortal Wkly Rep. 2015;71.",Current estimate of costs of lung cancer screening in the United States,MMWR Morb Mortal Wkly Rep,2015,71,,,,,Cornelius ME; Loretan CG; Wang TW
227,"Mariotto AB, Yabroff KR, Shao Y. Lung cancer costs by treatment strategy and phase of care among patients enrolled in Medicare. J Natl Cancer Inst. 2011;103.",Lung cancer costs by treatment strategy and phase of care among patients enrolled in Medicare,J Natl Cancer Inst,2011,103,,,,,Mariotto AB; Yabroff KR; Shao Y
228,"Schweigert M, Dubecz A, Beron M. Finding needles in a haystack: annual low-dose computed tomography screening reduces lung cancer mortality in a highrisk group. Cancer Epidemiol Biomarkers Prev. 2004;182.",Finding needles in a haystack: annual low-dose computed tomography screening reduces lung cancer mortality in a highrisk group,Cancer Epidemiol Biomarkers Prev,2004,182,,,,,Schweigert M; Dubecz A; Beron M
229,"Wisnivesky JP, Mushlin AI, Sicherman N et al.. The costeffectiveness of low-dose CT screening for lung cancer: preliminary results of baseline screening. Chest. 2002;124.",The costeffectiveness of low-dose CT screening for lung cancer: preliminary results of baseline screening,Chest,2002,124,,,,,Wisnivesky JP; Mushlin AI; Sicherman N; Henschke C; Hazelton T; Tockman M; Clark R
230,"Woloshin S, Schwartz LM, Black WC, Kramer B, Riley TL. Cancer screening campaigns--getting past uninformative persuasion. J Natl Cancer Inst. 2012;367:84.",Cancer screening campaigns--getting past uninformative persuasion,J Natl Cancer Inst,2012,367,,84,,,Woloshin S; Schwartz LM; Black WC; Kramer B; Riley TL
231,"Smith RA, Andrews KS, Brooks D. Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J Clin. 2014;67:1001764.","Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening",CA Cancer J Clin,2014,67,,1001764,,,Smith RA; Andrews KS; Brooks D
232,"Yousaf-Khan U, Van Der Aalst C, Jong PA. Risk stratification based on screening history: the NELSON lung cancer screening study. Thorax. 2017;72.",Risk stratification based on screening history: the NELSON lung cancer screening study,Thorax,2017,72,,,,,Yousaf-Khan U; Van Der Aalst C; Jong PA
